| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | CA2173543C Ceramide-type compounds, process for their preparation and uses thereof |
| 07/17/2001 | CA2151141C Mammalian receptors for interleukin-10 (il-10) |
| 07/17/2001 | CA2110519C Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits detection of bovine herpesvirus type 1 |
| 07/17/2001 | CA2074502C Vaccines |
| 07/17/2001 | CA2034025C Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049821A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 07/12/2001 | WO2001049775A2 Antisense antibacterial cell division composition and method |
| 07/12/2001 | WO2001049720A2 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049705A2 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | WO2001049699A1 Macrolide antiinfective agents |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049688A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049667A1 Method for preparing hydroxypicolinic acid derivatives |
| 07/12/2001 | WO2001049666A1 Picolinic acid derivatives and their use as fungicides |
| 07/12/2001 | WO2001049319A1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049306A1 Balanites aegyptiaca extracts for treatment of hiv/aids and leukemia |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049300A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 07/12/2001 | WO2001049283A1 Preparations for the non-traumatic excision of a nail |
| 07/12/2001 | WO2001049279A2 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/12/2001 | WO2001049274A2 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | WO2001049255A2 Methods and compositions for inhibiting adhesion by microorganisms |
| 07/12/2001 | WO2001049242A2 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000069391A3 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 07/12/2001 | WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 07/12/2001 | WO2000041528A9 Improved controlled release compositions and method |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007762 Process for macromolecularizing phenolic compounds etc. and use thereof |
| 07/12/2001 | US20010007745 Genetic engineering |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE10061801A1 New compositions containing hydrophilic film former, water and urea useful for non-traumatic removal of fungally infected areas in finger- and toenails |
| 07/12/2001 | CA2397714A1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396306A1 Method for preparing hydroxypicolinic acid derivatives |
| 07/12/2001 | CA2396299A1 Picolinic acid derivatives and their use as fungicides |
| 07/12/2001 | CA2396276A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | CA2396173A1 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | CA2396068A1 Antisense antibacterial cell division composition and method |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395887A1 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | CA2395642A1 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/12/2001 | CA2395610A1 Methods and compositions for inhibiting adhesion by microorganisms |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2328634A1 Assay method |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114826A2 Novel antibacterial and prokinetic macrolides |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114064A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114039A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114032A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1113821A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113817A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 07/11/2001 | EP1113816A2 Novel influenza virus vaccine composition |
| 07/11/2001 | EP1113812A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
| 07/11/2001 | EP1113809A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 07/11/2001 | EP1113806A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 07/11/2001 | EP1113803A1 Antiviral combinations comprising lamivudine and abacavir |
| 07/11/2001 | EP1113802A2 Antiviral combinations of lamivudine and adefovir |
| 07/11/2001 | EP1113794A2 Methods of treating viral disease |
| 07/11/2001 | EP1015452A4 Optionally protected 3-hydroxymethyl carbapenems and synthesis |
| 07/11/2001 | EP0912509B1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |